Adipose-Derived Stem Cells and Ceiling Culture-Derived Preadipocytes Cultured from Subcutaneous Fat Tissue Differ in Their Epigenetic Characteristics and Osteogenic Potential.


Journal

Plastic and reconstructive surgery
ISSN: 1529-4242
Titre abrégé: Plast Reconstr Surg
Pays: United States
ID NLM: 1306050

Informations de publication

Date de publication:
09 2019
Historique:
entrez: 29 8 2019
pubmed: 29 8 2019
medline: 11 1 2020
Statut: ppublish

Résumé

Adipose-derived stem cells and ceiling culture-derived preadipocytes can be harvested from subcutaneous adipose tissue. Little is known about the epigenetic differences, which may contribute to differences in osteogenic potential, between these cell types. The purpose of this study was to address the osteogenic potential and underlying epigenetic status of adipose-derived stem cells and ceiling culture-derived preadipocytes. Adipose-derived stem cells and ceiling culture-derived preadipocytes were cultured from abdominal subcutaneous fat tissues of four metabolically healthy, lean female patients. After 7 weeks of culture, cellular responses to osteogenic differentiation media were examined. To evaluate the osteogenic potentials of undifferentiated adipose-derived stem cells and ceiling culture-derived preadipocytes, two types of epigenetic assessment were performed using next-generation sequencing: DNA methylation assays with the Human Methylation 450K BeadChip, and chromatin immunoprecipitation assays for trimethylation of histone H3 at lysine 4. Human ceiling culture-derived preadipocytes showed greater osteogenic differentiation ability than did adipose-derived stem cells. In an epigenetic survey of the promoters of four osteogenic regulator genes (RUNX2, SP7, ATF4, and BGLAP), the authors found a general trend toward decreased CpG methylation and increased trimethylation of histone H3 at lysine 4 levels in ceiling culture-derived preadipocytes as compared to adipose-derived stem cells, indicating that these genes were more likely to be highly expressed in ceiling culture-derived preadipocytes. The surveyed epigenetic differences between adipose-derived stem cells and ceiling culture-derived preadipocytes were consistent with the observed differences in osteogenic potential. These results enhance the authors' understanding of these cells and will facilitate their further application in regenerative medicine.

Sections du résumé

BACKGROUND
Adipose-derived stem cells and ceiling culture-derived preadipocytes can be harvested from subcutaneous adipose tissue. Little is known about the epigenetic differences, which may contribute to differences in osteogenic potential, between these cell types. The purpose of this study was to address the osteogenic potential and underlying epigenetic status of adipose-derived stem cells and ceiling culture-derived preadipocytes.
METHODS
Adipose-derived stem cells and ceiling culture-derived preadipocytes were cultured from abdominal subcutaneous fat tissues of four metabolically healthy, lean female patients. After 7 weeks of culture, cellular responses to osteogenic differentiation media were examined. To evaluate the osteogenic potentials of undifferentiated adipose-derived stem cells and ceiling culture-derived preadipocytes, two types of epigenetic assessment were performed using next-generation sequencing: DNA methylation assays with the Human Methylation 450K BeadChip, and chromatin immunoprecipitation assays for trimethylation of histone H3 at lysine 4.
RESULTS
Human ceiling culture-derived preadipocytes showed greater osteogenic differentiation ability than did adipose-derived stem cells. In an epigenetic survey of the promoters of four osteogenic regulator genes (RUNX2, SP7, ATF4, and BGLAP), the authors found a general trend toward decreased CpG methylation and increased trimethylation of histone H3 at lysine 4 levels in ceiling culture-derived preadipocytes as compared to adipose-derived stem cells, indicating that these genes were more likely to be highly expressed in ceiling culture-derived preadipocytes.
CONCLUSIONS
The surveyed epigenetic differences between adipose-derived stem cells and ceiling culture-derived preadipocytes were consistent with the observed differences in osteogenic potential. These results enhance the authors' understanding of these cells and will facilitate their further application in regenerative medicine.

Identifiants

pubmed: 31461020
doi: 10.1097/PRS.0000000000005913
pii: 00006534-201909000-00025
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

644-655

Commentaires et corrections

Type : CommentIn

Références

Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. 2001;7:211–228.
Sugihara H, Yonemitsu N, Miyabara S, Yun K. Primary cultures of unilocular fat cells: Characteristics of growth in vitro and changes in differentiation properties. Differentiation 1986;31:42–49.
Asada S, Kuroda M, Aoyagi Y, et al. Ceiling culture-derived proliferative adipocytes retain high adipogenic potential suitable for use as a vehicle for gene transduction therapy. Am J Physiol Cell Physiol. 2011;301:C181–C185.
Matsumoto T, Kano K, Kondo D, et al. Mature adipocyte-derived dedifferentiated fat cells exhibit multilineage potential. J Cell Physiol. 2008;215:210–222.
Kikuta S, Tanaka N, Kazama T, et al. Osteogenic effects of dedifferentiated fat cell transplantation in rabbit models of bone defect and ovariectomy-induced osteoporosis. Tissue Eng Part A 2013;19:1792–1802.
Orbay H, Devi K, Williams PA, Dehghani T, Silva EA, Sahar DE. Comparison of endothelial differentiation capacities of human and rat adipose-derived stem cells. Plast Reconstr Surg. 2016;138:1231–1241.
Rezzadeh KS, Hokugo A, Jewett A, et al. Natural killer cells differentiate human adipose-derived stem cells and modulate their adipogenic potential. Plast Reconstr Surg. 2015;136:503–510.
Saler M, Caliogna L, Botta L, Benazzo F, Riva F, Gastaldi G. hASC and DFAT, multipotent stem cells for regenerative medicine: A comparison of their potential differentiation in vitro. Int J Mol Sci. 2017;18:e2699.
Kosaka K, Kubota Y, Adachi N, et al. Human adipocytes from the subcutaneous superficial layer have greater adipogenic potential and lower PPAR-γ DNA methylation levels than deep layer adipocytes. Am J Physiol Cell Physiol. 2016;311:C322–C329.
Lough DM, Chambers C, Germann G, et al. Regulation of ADSC osteoinductive potential using Notch pathway inhibition and gene rescue: A potential on/off switch for clinical applications in bone formation and reconstructive efforts. Plast Reconstr Surg. 2016;138:642e–652e.
Kishimoto N, Momota Y, Hashimoto Y, et al. The osteoblastic differentiation ability of human dedifferentiated fat cells is higher than that of adipose stem cells from the buccal fat pad. Clin Oral Investig. 2014;18:1893–1901.
Goldberg AD, Allis CD, Bernstein E. Epigenetics: A landscape takes shape. Cell 2007;128:635–638.
Jones PA. Functions of DNA methylation: Islands, start sites, gene bodies and beyond. Nat Rev Genet. 2012;13:484–492.
Santos-Rosa H, Schneider R, Bannister AJ, et al. Active genes are tri-methylated at K4 of histone H3. Nature 2002;419:407–411.
Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 2007;130:77–88.
Barski A, Cuddapah S, Cui K, et al. High-resolution profiling of histone methylations in the human genome. Cell 2007;129:823–837.
Youkou A, Hasegawa T, Suzuki K, et al. Influence of obesity on control in asthmatic Japanese patients defined by the Japanese definition of obesity. Intern Med. 2011;50:1911–1916.
The Regents of the University of California Santa Cruz. Genome browser gateway: Human assembly: Feb. 2009 (GRCh37/hg19). Available at: http://genome.ucsc.edu/cgi-bin/hgGateway?db=hg19&redirect=manual&source=genome.ucsc.edu. Accessed March 21, 2018.
Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 2010;26:589–595.
Robinson JT, Thorvaldsdóttir H, Winckler W, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24–26.
Thorvaldsdóttir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): High-performance genomics data visualization and exploration. Brief Bioinform. 2013;14:178–192.
Nagano H, Hashimoto N, Nakayama A, et al. p53-inducible DPYSL4 associates with mitochondrial supercomplexes and regulates energy metabolism in adipocytes and cancer cells. Proc Natl Acad Sci USA. 2018;115:8370–8375.
The Regents of the University of California. Integrated Genomics Viewer. Available at: http://software.broadinstitute.org/software/igv/. Accessed August 31, 2018.
Stock M, Otto F. Control of RUNX2 isoform expression: The role of promoters and enhancers. J Cell Biochem. 2005;95:506–517.
Xiao ZS, Hjelmeland AB, Quarles LD. Selective deficiency of the “bone-related” Runx2-II unexpectedly preserves osteoblast-mediated skeletogenesis. J Biol Chem. 2004;279:20307–20313.
Sudhakar S, Katz MS, Elango N. Analysis of type-I and type-II RUNX2 protein expression in osteoblasts. Biochem Biophys Res Commun. 2001;286:74–79.
Liu JC, Lengner CJ, Gaur T, et al. Runx2 protein expression utilizes the Runx2 P1 promoter to establish osteoprogenitor cell number for normal bone formation. J Biol Chem. 2011;286:30057–30070.
Doecke JD, Day CJ, Stephens AS, et al. Association of functionally different RUNX2 P2 promoter alleles with BMD. J Bone Miner Res. 2006;21:265–273.
Sinha KM, Yasuda H, Zhou X, deCrombrugghe B. Osterix and NO66 histone demethylase control the chromatin of Osterix target genes during osteoblast differentiation. J Bone Miner Res. 2014;29:855–865.
Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002;108:17–29.
Yang X, Karsenty G. ATF4, the osteoblast accumulation of which is determined post-translationally, can induce osteoblast-specific gene expression in non-osteoblastic cells. J Biol Chem. 2004;279:47109–47114.
Dobreva G, Chahrour M, Dautzenberg M, et al. SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell 2006;125:971–986.
Xiao G, Jiang D, Ge C, et al. Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression. J Biol Chem. 2005;280:30689–30696.
Scioli MG, Bielli A, Gentile P, Cervelli V, Orlandi A. Combined treatment with platelet-rich plasma and insulin favours chondrogenic and osteogenic differentiation of human adipose-derived stem cells in three-dimensional collagen scaffolds. J Tissue Eng Regen Med. 2017;11:2398–2410.
Tansriratanawong K, Tamaki Y, Ishikawa H, Sato S. Co-culture with periodontal ligament stem cells enhances osteogenic gene expression in de-differentiated fat cells. Hum Cell 2014;27:151–161.
Justesen J, Pedersen SB, Stenderup K, Kassem M. Subcutaneous adipocytes can differentiate into bone-forming cells in vitro and in vivo. Tissue Eng. 2004;10:381–391.
Oki Y, Watanabe S, Endo T, Kano K. Mature adipocyte-derived dedifferentiated fat cells can trans-differentiate into osteoblasts in vitro and in vivo only by all-trans retinoic acid. Cell Struct Funct. 2008;33:211–222.
Fu X, Li Y, Huang T, et al. Runx2/osterix and zinc uptake synergize to orchestrate osteogenic differentiation and citrate containing bone apatite formation. Adv Sci (Weinh.) 2018;5:1700755.
Ducy P, Karsenty G. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol. 1995;15:1858–1869.
Saito A, Ochiai K, Kondo S, et al. Endoplasmic reticulum stress response mediated by the PERK-eIF2(alpha)-ATF4 pathway is involved in osteoblast differentiation induced by BMP2. J Biol Chem. 2011;286:4809–4818.
Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007;130:456–469.
Oury F, Sumara G, Sumara O, et al. Endocrine regulation of male fertility by the skeleton. Cell 2011;144:796–809.
Kuroda M, Tominaga A, Nakagawa K, et al. DNA methylation suppresses leptin gene in 3T3-L1 adipocytes. PLoS One 2016;11:e0160532.
Hilton IB, D’Ippolito AM, Vockley CM, et al. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat Biotechnol. 2015;33:510–517.
Charles-de-Sa L, Gontijo-de-Amorim NF, Maeda Takiya C, et al. Antiaging treatment of the facial skin by fat graft and adipose-derived stem cells. Plast Reconstr Surg. 2015;135:999–1009.
Levi B, Glotzbach JP, Sorkin M, et al. Molecular analysis and differentiation capacity of adipose-derived stem cells from lymphedema tissue. Plast Reconstr Surg. 2013;132:580–589.
Lu F, Mizuno H, Uysal CA, Cai X, Ogawa R, Hyakusoku H. Improved viability of random pattern skin flaps through the use of adipose-derived stem cells. Plast Reconstr Surg. 2008;121:50–58.
Soejima K, Kashimura T, Asami T, Kazama T, Matsumoto T, Nakazawa H. Effects of mature adipocyte-derived dedifferentiated fat (DFAT) cells on generation and vascularisation of dermis-like tissue after artificial dermis grafting. J Plast Surg Hand Surg. 2015;49:25–31.
Sowa Y, Kishida T, Imura T, et al. Adipose-derived stem cells promote peripheral nerve regeneration in vivo without differentiation into Schwann-like lineage. Plast Reconstr Surg. 2016;137:318e–330e.
Wu W, Niklason L, Steinbacher DM. The effect of age on human adipose-derived stem cells. Plast Reconstr Surg. 2013;131:27–37.
Yoshida S, Yoshimoto H, Hirano A, Akita S. Wound healing and angiogenesis through combined use of a vascularized tissue flap and adipose-derived stem cells in a rat hindlimb irradiated ischemia model. Plast Reconstr Surg. 2016;137:1486–1497.
Jumabay M, Abdmaulen R, Urs S, et al. Endothelial differentiation in multipotent cells derived from mouse and human white mature adipocytes. J Mol Cell Cardiol. 2012;53:790–800.
Nakayama E, Matsumoto T, Kazama T, Kano K, Tokuhashi Y. Transplantation of dedifferentiation fat cells promotes intervertebral disc regeneration in a rat intervertebral disc degeneration model. Biochem Biophys Res Commun. 2017;493:1004–1009.
Yoshimura K, Suga H, Eto H. Adipose-derived stem/progenitor cells: Roles in adipose tissue remodeling and potential use for soft tissue augmentation. Regen Med. 2009;4:265–273.
Ito M, Bujo H, Takahashi K, Arai T, Tanaka I, Saito Y. Implantation of primary cultured adipocytes that secrete insulin modifies blood glucose levels in diabetic mice. Diabetologia 2005;48:1614–1620.
Kubota Y, Unoki H, Bujo H, et al. Low-dose GH supplementation reduces the TLR2 and TNF-alpha expressions in visceral fat. Biochem Biophys Res Commun. 2008;368:81–87.
Kuramochi D, Unoki H, Bujo H, et al. Matrix metalloproteinase 2 improves the transplanted adipocyte survival in mice. Eur J Clin Invest. 2008;38:752–759.
Kuroda M, Aoyagi Y, Asada S, et al. Ceiling culture-derived proliferative adipocytes are possible delivery vehicle for enzyme replacement therapy in lecithin:cholesterol acyltransferase deficiency. Open Gene Ther J. 2011;4:1–10.
Runyan CM, Jones DC, Bove KE, Maercks RA, Simpson DS, Taylor JA. Porcine allograft mandible revitalization using autologous adipose-derived stem cells, bone morphogenetic protein-2, and periosteum. Plast Reconstr Surg. 2010;125:1372–1382.
Smith DM, Cooper GM, Afifi AM, et al. Regenerative surgery in cranioplasty revisited: The role of adipose-derived stem cells and BMP-2. Plast Reconstr Surg. 2011;128:1053–1060.
Yalom A, Hokugo A, Sorice S, et al. In vitro osteoinductive effects of hydroxycholesterol on human adipose-derived stem cells are mediated through the hedgehog signaling pathway. Plast Reconstr Surg. 2014;134:960–968.

Auteurs

Yoshitaro Sasahara (Y)

From the Departments of Plastic Surgery and Molecular Diagnosis and the Center for Advanced Medicine, Chiba University; the Department of General Surgery, National Organization Hospital Mito Medical Center; and the Department of Research and Development, Toho University.

Yoshitaka Kubota (Y)

From the Departments of Plastic Surgery and Molecular Diagnosis and the Center for Advanced Medicine, Chiba University; the Department of General Surgery, National Organization Hospital Mito Medical Center; and the Department of Research and Development, Toho University.

Kentaro Kosaka (K)

From the Departments of Plastic Surgery and Molecular Diagnosis and the Center for Advanced Medicine, Chiba University; the Department of General Surgery, National Organization Hospital Mito Medical Center; and the Department of Research and Development, Toho University.

Naoki Adachi (N)

From the Departments of Plastic Surgery and Molecular Diagnosis and the Center for Advanced Medicine, Chiba University; the Department of General Surgery, National Organization Hospital Mito Medical Center; and the Department of Research and Development, Toho University.

Yoshihisa Yamaji (Y)

From the Departments of Plastic Surgery and Molecular Diagnosis and the Center for Advanced Medicine, Chiba University; the Department of General Surgery, National Organization Hospital Mito Medical Center; and the Department of Research and Development, Toho University.

Hidekazu Nagano (H)

From the Departments of Plastic Surgery and Molecular Diagnosis and the Center for Advanced Medicine, Chiba University; the Department of General Surgery, National Organization Hospital Mito Medical Center; and the Department of Research and Development, Toho University.

Shinsuke Akita (S)

From the Departments of Plastic Surgery and Molecular Diagnosis and the Center for Advanced Medicine, Chiba University; the Department of General Surgery, National Organization Hospital Mito Medical Center; and the Department of Research and Development, Toho University.

Masayuki Kuroda (M)

From the Departments of Plastic Surgery and Molecular Diagnosis and the Center for Advanced Medicine, Chiba University; the Department of General Surgery, National Organization Hospital Mito Medical Center; and the Department of Research and Development, Toho University.

Tomoaki Tanaka (T)

From the Departments of Plastic Surgery and Molecular Diagnosis and the Center for Advanced Medicine, Chiba University; the Department of General Surgery, National Organization Hospital Mito Medical Center; and the Department of Research and Development, Toho University.

Hideaki Bujo (H)

From the Departments of Plastic Surgery and Molecular Diagnosis and the Center for Advanced Medicine, Chiba University; the Department of General Surgery, National Organization Hospital Mito Medical Center; and the Department of Research and Development, Toho University.

Nobuyuki Mitsukawa (N)

From the Departments of Plastic Surgery and Molecular Diagnosis and the Center for Advanced Medicine, Chiba University; the Department of General Surgery, National Organization Hospital Mito Medical Center; and the Department of Research and Development, Toho University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH